Line 46: | Line 46: | ||
<p style="text-align: center;"><strong>The applications of PHAs present and future</strong></p> | <p style="text-align: center;"><strong>The applications of PHAs present and future</strong></p> | ||
<p style ="text-align:center;"><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/9/94/T--Edinburgh_OG--pha_apps.png | <p style ="text-align:center;"><img style="display: block; margin-left: auto; margin-right: auto;" src="https://static.igem.org/mediawiki/2018/9/94/T--Edinburgh_OG--pha_apps.png | ||
− | " alt="" width=" | + | " alt="" width="840" height="800" /></p> |
<p style="text-align: center;">Source: Cambridge Consultants 2018 <a href="https://www.cambridgeconsultants.com/insights/bioplastics-pha-whitepaper">White Paper</a> report</p> | <p style="text-align: center;">Source: Cambridge Consultants 2018 <a href="https://www.cambridgeconsultants.com/insights/bioplastics-pha-whitepaper">White Paper</a> report</p> | ||
Revision as of 01:20, 18 October 2018